Wegovy Nausea: How Common, How Long It Lasts, What Helps
Yes. In the Wegovy trials, 44% of people on 2.4 mg had nausea, against 16% on placebo: about 3 times the placebo rate. It is the most common side effect in that table. Smaller, slower meals help most.
- In the Wegovy label
- Yes, with a rate
- On Wegovy 2.4 mg
- 44%
- On placebo
- 16%
- Rank in the label table
- 1 of 19
Wegovy: key facts
About 1 week is its half-life. By 7 days, half is gone, and about 3% remains after five half-lives (35 d).
In STEP 1 over 68 weeks, the figure was 14.9% of body weight, compared with 2.4% on placebo.
The maker's price page lists monthly price points in US dollars. These cover list price and self-pay offers.
Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.
How often it appears: Wegovy versus placebo
In the label trials, Wegovy nausea is shown for each dose group. The same trial lists a placebo group for comparison.
| Medicine and dose | Nausea | Placebo | More than placebo | People in the trials |
|---|---|---|---|---|
| Wegovy 2.4 mg | 44% | 16% | +28 points | Adults with obesity or overweight (weight management) |
| Wegovy 2.4 mg | 35% | 13% | +22 points | Adults with obesity (7.2 mg dose trials) |
| Wegovy 7.2 mg | 39% | 13% | +26 points | Adults with obesity (7.2 mg dose trials) |
| Wegovy 2.4 mg | 42% | 18% | +24 points | Children 12 and older with obesity |
Source: Wegovy label (DailyMed).
Nausea: Wegovy and other GLP-1s
Each label covers its own trials, which involved different groups of people. Use it as a rough guide.
The table also lists the pill forms: Rybelsus, Foundayo.
| Medicine | Highest rate in the label | Dose group | Placebo | People in the trials |
|---|---|---|---|---|
| Wegovy | 44% | 2.4 mg | 16% | Adults with obesity or overweight (weight management) |
| Byetta | 44% | all doses | 18% | Adults with type 2 diabetes |
 Saxenda | 39.3% | all doses | 13.8% | Adults with obesity or overweight (weight management) |
 Foundayo | 35% | 17.2 mg | 10% | Adults with obesity or overweight (weight management) |
 Zepbound | 29% | 10 mg | 8% | Adults with obesity or overweight (weight management) |
 Trulicity | 21.1% | 1.5 mg | 5.3% | Adults with type 2 diabetes |
 Ozempic | 20.3% | 1 mg | 6.1% | Adults with type 2 diabetes |
 Rybelsus | 20% | 14 mg | 6% | Adults with type 2 diabetes |
 Victoza | 20% | 1.8 mg | 5% | Adults with type 2 diabetes |
 Mounjaro | 18% | 15 mg | 4% | Adults with type 2 diabetes |
Sources: Ozempic label (DailyMed), Wegovy label (DailyMed), Rybelsus label (DailyMed), Mounjaro label (DailyMed), Zepbound label (DailyMed), Foundayo label (DailyMed), Trulicity label (DailyMed), Saxenda label (DailyMed), Victoza label (DailyMed), Byetta label (DailyMed).
Source: FDA label (DailyMed).
Why it happens on Wegovy
These medicines slow down how quickly the stomach empties. When food stays in your stomach longer, you may feel nausea, especially after a large or fatty meal.
Source: health.clevelandclinic.org.
What the Wegovy label says
The label lists nausea in these exact words:
“The most common adverse reactions leading to discontinuation were nausea (1.8% versus 0.2%), vomiting (1.2% versus 0%), and diarrhea (0.7% versus 0.1%) for WEGOVY and”
Source: FDA label (DailyMed).
What helps, step by step
- Have sips of ginger or peppermint tea with no sweetener.
- After eating, remain upright instead of lying down.
- Ask your prescriber about nausea medicine to have ready.
- Eat smaller meals and stop when you feel full. These medicines slow down how fast your stomach empties.
- Eat slowly. Your brain needs time to recognize when you are full.
- Eat less fatty, greasy, and sugary food, as these foods often cause symptoms.
- Tell your prescriber if the nausea does not ease. They may slow the dose increases or suggest another GLP-1.
Before taking anything from the drugstore, check it with the GLP-1 interactions checker.
Source: health.clevelandclinic.org.